ALLANTOIN;
ALLANTOIN;
CAS NUMBER; 97-59-6
EC NUMBER; 202-592-8
SYNOYMS; Glyoxyldiureide, 5-Ureidohydantoin; Allantoin; allantoin; 97-59-6; 5-Ureidohydantoin; Glyoxyldiureide; 1-(2,5-dioxoimidazolidin-4-yl)urea; Glyoxyldiureid; Allantol; Cordianine; Sebical; Alantan; AVC/Dienestrolcream; Urea, (2,5-dioxo-4-imidazolidinyl)-; Hydantoin, 5-ureido-; Cutemol emollient; Uniderm A; Glyoxylic diureide; (2,5-Dioxo-4-imidazolidinyl)urea; Psoralon; Septalan; Caswell No. 024; (2,5-dioxoimidazolidin-4-yl)urea; Glyoxylic(acid) diureide; 5-Ureido-2,4-imidazolidindion; NSC 7606; Ureidohydantoin; CCRIS 1958; Allantoin [USAN:BAN]; Fancol TOIN; 5-Ureidohydrantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; EPA Pesticide Chemical Code 085701; AI3-15281; NSC7606; 2,5-Dioxo-4-imidazolidinyl-urea; Allantoin (JAN/USP); EINECS 202-592-8; BRN 0102364; urea, N-(2,5-dioxo-4-imidazolidinyl)-
MLS000737882; C4H6N4O3; CHEBI:15676; 4-ureido-2,5-Imidazolidinedione; POJWUDADGALRAB-UHFFFAOYSA-N; MFCD00005260; N-(2,5-dioxoimidazolidin-4-yl)urea; DSSTox_CID_43Herpecin L; D00121; DSSTox_RID_75334; DSSTox_GSID_20043; (S)-Allantoin; N-[2,5-dioxoimidazolidin-4-yl]urea; SMR000528073; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amideSR-01000766252; allantion; Allantoinum; Allantoi; Hemocane; DL-Allantoin; HSDB 7490; Allantoin [USAN:USP:BAN:JAN]; CAS-97-59-6; Prestwick_11; NCGC00016358-01; 5-ureido-Hydantoin; Allantoin (8CI); 5-eaAoAOEO; (+/-)-Allantoin; Spectrum_001078; ACMC-209twn; Prestwick0_000002; Prestwick1_000002; Prestwick2_000002; Prestwick3_000002; Spectrum2_000219; Spectrum3_000876; Spectrum4_000716; Spectrum5_001526; bmse000437; D01HNL; AC1L18PM; AC1Q2AJ8; SCHEMBL3208; Oprea1_621175; Allantoin, 98% 250g; BSPBio_000003; BSPBio_002551; KBioGR_001271; KBioSS_001558; 5-25-15-00338 (Beilstein Handbook Reference); KSC679I2B; MLS002473300; Allantoin, analytical standard; Bio-0219; DivK1c_000281; SPECTRUM1500801; SPBio_000237; SPBio_001924; BPBio1_000005; CHEMBL593429; 5-Ureido-2,4-imidazolidindione; DTXSID3020043
CTK5H9420; HMS500O03; KBio1_000281; KBio2_001558; KBio2_004126; KBio2_006694; KBio3_002051; Allantoin, >=98.0% (N); MolPort-001-779-876; NINDS_000281; Urea,5-dioxo-4-imidazolidinyl)-; HMS1568A05; HMS1921I10; HMS2092K16; HMS2095A05; HMS2268N08; Pharmakon1600-01500801; component of Skin-balm (Salt/Mix); HY-N0543; NSC-7606; 2,5-Imidazolidinedione, 4-ureido-; Tox21_110395; Tox21_202087; Tox21_302912; ANW-43029; BBL027508; CCG-39781; NSC757792; SBB003997; STL373778; AKOS000120642; AKOS016038547Tox21_110395_1; CS-7741; LS-7181; MCULE-1008326286; NSC-757792; RL06095; RTR-038622; SDCCGMLS-0066595.P001; 1-(2,5-Dioxoimidazolidin-4-yl);urea; IDI1_000281; KS-0000005S; Allantoin, p.a., 98.5-101.0%; N-(2,5-Dioxo-4-imidazolidinyl)urea #; NCGC00094854-01; NCGC00094854-02; NCGC00094854-03; NCGC00094854-04; NCGC00094854-05; NCGC00094854-07; NCGC00256403-01; NCGC00259636-01; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; 4CN-0784; 5377-33-3; AC-11040; AK-77679; AN-24454; AS-13865; H736; NCI60_041675; SC-18051; N-(2,5-Dioxo-4(1h)-imidazolidinyl)urea; SBI-0051759.P002; KB-212681; ST2408512; TR-038622; A0211; AB00052307; BG01500390; FT-0604592; ST50308144; C01551; J10470; M-5668; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); AB00052307_11; I05-0376; J-522839; SR-01000766252-2; SR-01000766252-3; SR-01000766252-4
W-100104; I14-13401; Allantoin, European Pharmacopoeia (EP) Reference Standard; A999F0D6-0285-41D9-A6BA-B705987B663C; Allantoin, United States Pharmacopeia (USP) Reference Standard; Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material; Ao>>u(1/4)a paragraph signthorn-micro feminineA Ie-2,4- paragraph signthornI feminine; 37305-69-4; 5-Ureidohydantoin; Glyoxyldiureide; Glyoxylic diureide; Cordianine; Glyoxyldiureid; (2,5-Dioxo-4-imidazolidinyl)urea; 58308-55-7; Allantoin; Herpecin L; Herpecin-L; HerpecinL; Sebical; Woun’dres; 5-Ureidohydantoin, Glyoxylic(acid) diureide; (2,5-DIOXO-4-IMIDAZOLIDINYL) – UREA; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; GLYOXYLDIUREID; GLYOXYLDIUREIDE; GLYOXYLIC DIUREIDE; UREA, (2,5-DIOXO-4-IMIDAZOLIDINYL) -; UREA, (2,5DIOXO4IMIDAZOLIDINYL) ; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; AI3-15281; (±)-Allantoin; (±)-Allantoin; 1-(2,5-Dioxo-4-imidazolidinyl)harnstoff [German] [ACD/IUPAC Name]; 1-(2,5-Dioxo-4-imidazolidinyl)urea [ACD/IUPAC Name]; 1-(2,5-Dioxo-4-imidazolidinyl)urée [French] [ACD/IUPAC Name]; 1-(2,5-Dioxoimidazolidin-4-yl)harnstoff; 1-(2,5-dioxoimidazolidin-4-yl)urea; 2,5-Dioxo-4-imidazolidinyl-urea; 202-592-8 [EINECS]; 344S277G0Z; 39669-95-9 [RN]; 4H-imidazole-2,5-diol, 4-[(hydroxyiminomethyl)amino]-4-ureido-2,5-Imidazolidinedione; 5-Ureido-2,4-imidazolidindion; 5-ureido-Hydantoin; 97-59-6 [RN]; Allantoin [BAN] [JAN] [USAN] [USP] [Wiki]; Allantoin (8CI); DL-Allantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; UNII:344S277G0Z; Urea, (2,5-dioxo-4-imidazolidinyl)-; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); Urea, N-(2,5-dioxo-4-imidazolidinyl)- [ACD/Index Name]; 5-Ureidohydrantoin; Fancol TOIN; (2,5-diketoimidazolidin-4-yl)urea; (2,5-dioxo-4-imidazolidinyl)-urea; (2,5-Dioxo-4-imidazolidinyl)urea; (2,5-dioxoimidazolidin-4-yl)urea; (2,5-Dioxo-imidazolidin-4-yl)-urea; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; [97-59-6]; 2,5-dioxoimidazolidin-4-ylurea; 2,5-Imidazolidinedione, 4-ureido-; 5-Ureido-2,4-imidazolidindione; 5-Ureido-2,4-imidazolidinedione; Actinac; Alantan; Allantoi; allantoin 98%; Allantoin CTFAallantoin standard; allantoin, ???; allantoin, 98%; allantoin, powder; Allantoinum; Allantol; Alloxantin [Wiki]; Alphosyl; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; AVC/Dienestrolcream; c4h6n4o3; Cordianin; Cutemol emollient; Dermalex; DL-ALLANTOIN-5-13C,1-15N; Glyoxyldiureid; Glyoxylic diureide; Glyoxylic(acid) diureide; Hemocane; Hydantoin, 5-ureido-; MFCD00005260 [MDL number]; N-(2,5-dioxoimidazolidin-4-yl)urea; Paxyl [Wiki]; Pharmakon1600-01500801; ProClin 300; PsoralonS-allantoin; Sebical; Septalan; Uniderm A; Urea, (2, 5-dioxo-4-imidazolidinyl)-; Ureidohydantoin.; YT1600000; ??? [Chinese]; (2,5-Dioxo-4-imidazolidinyl)urea2,5-Dioxo-4-imidazolidinyl-urea; 4-ureido-2,5-imidazolidinedione; 5-Ureido-2,4-imidazolidindione; 5-Ureidohydantoin; 5-ureidohydantoin; glyoxyldiureide; N-(2,5-Dioxo-4-imidazolidinyl)urea; InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11); POJWUDADGALRAB-UHFFFAOYSA-N; Urea, (2,5-dioxo-4-imidazolidinyl)-; 1-(2,5-dioxoimidazolidin-4-yl)urea; Urea, (2,5-dioxo-4-imidazolidinyl)-; Allantol; AVC/Dienestrolcream; Cordianine; Glyoxyldiureid; Glyoxyldiureide; Hydantoin, 5-ureido-; Sebical; 5-Ureidohydantoin; 2,5-Dioxo-4-imidazolidinyl-urea; Alantan; Glyoxylic diureide; 5-Ureidohydrantoin; Fancol TOIN; Psoralon; Septalan; 2,5-Imidazolidinedione, 4-ureido-; NSC 7606; Urea, N-(2,5-dioxo-4-imidazolidinyl)-; Glyoxyldiureide, 5-Ureidohydantoin; Allantoin; allantoin; 97-59-6; 5-Ureidohydantoin; Glyoxyldiureide; 1-(2,5-dioxoimidazolidin-4-yl)urea; Glyoxyldiureid; Allantol; Cordianine; Sebical; Alantan; AVC/Dienestrolcream; Urea, (2,5-dioxo-4-imidazolidinyl)-; Hydantoin, 5-ureido-; Cutemol emollient; Uniderm A; Glyoxylic diureide; (2,5-Dioxo-4-imidazolidinyl)urea; Psoralon; Septalan; Caswell No. 024; (2,5-dioxoimidazolidin-4-yl)urea; Glyoxylic(acid) diureide; 5-Ureido-2,4-imidazolidindion; NSC 7606; Ureidohydantoin; CCRIS 1958; Allantoin [USAN:BAN]; Fancol TOIN; 5-Ureidohydrantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; EPA Pesticide Chemical Code 085701; AI3-15281; NSC7606; 2,5-Dioxo-4-imidazolidinyl-urea; Allantoin (JAN/USP); EINECS 202-592-8; BRN 0102364; urea, N-(2,5-dioxo-4-imidazolidinyl)-; MLS000737882; C4H6N4O3; CHEBI:15676; 4-ureido-2,5-Imidazolidinedione; POJWUDADGALRAB-UHFFFAOYSA-N; MFCD00005260; N-(2,5-dioxoimidazolidin-4-yl)urea; DSSTox_CID_43; Herpecin L; D00121; DSSTox_RID_75334; DSSTox_GSID_20043; (S)-Allantoin; N-[2,5-dioxoimidazolidin-4-yl]urea; SMR000528073; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; SR-01000766252; allantion; Allantoinum; Allantoi; Hemocane; DL-Allantoin; HSDB 7490; Allantoin [USAN:USP:BAN:JAN]; CAS-97-59-6; Prestwick_11; NCGC00016358-01; 5-ureido-Hydantoin; Allantoin (8CI); 5-eaAoAOEO; (+/-)-Allantoin; Spectrum_001078; ACMC-209twn; Prestwick0_000002; Prestwick1_000002; Prestwick2_000002; Prestwick3_000002; Spectrum2_000219; Spectrum3_000876; Spectrum4_000716; Spectrum5_001526; bmse000437; D01HNL; AC1L18PM; AC1Q2AJ8; SCHEMBL3208; Oprea1_621175; Allantoin, 98% 250g; BSPBio_000003; BSPBio_002551; KBioGR_001271; KBioSS_001558; 5-25-15-00338 (Beilstein Handbook Reference); KSC679I2B; MLS002473300; Allantoin, analytical standard; Bio-0219; DivK1c_000281; SPECTRUM1500801; SPBio_000237; SPBio_001924; BPBio1_000005; CHEMBL593429; 5-Ureido-2,4-imidazolidindione; DTXSID3020043; CTK5H9420; HMS500O03; KBio1_000281; KBio2_001558; KBio2_004126; KBio2_006694; KBio3_002051; Allantoin, >=98.0% (N); MolPort-001-779-876; NINDS_000281; Urea,5-dioxo-4-imidazolidinyl)-; HMS1568A05; HMS1921I10; HMS2092K16; HMS2095A05; HMS2268N08; Pharmakon1600-01500801; component of Skin-balm (Salt/Mix); HY-N0543; NSC-7606; 2,5-Imidazolidinedione, 4-ureido-; Tox21_110395; Tox21_202087; Tox21_302912; ANW-43029; BBL027508; CCG-39781; NSC757792; SBB003997; STL373778; AKOS000120642; AKOS016038547; Tox21_110395_1; CS-7741; LS-7181; MCULE-1008326286; NSC-757792; RL06095; RTR-038622; SDCCGMLS-0066595.P001; 1-(2,5-Dioxoimidazolidin-4-yl);urea; IDI1_000281; KS-0000005S; Allantoin, p.a., 98.5-101.0%; N-(2,5-Dioxo-4-imidazolidinyl)urea #; NCGC00094854-01; NCGC00094854-02; NCGC00094854-03; NCGC00094854-04; NCGC00094854-05; NCGC00094854-07; NCGC00256403-01; NCGC00259636-01; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; 4CN-0784; 5377-33-3; AC-11040; AK-77679; AN-24454; AS-13865; H736; NCI60_041675; SC-18051; N-(2,5-Dioxo-4(1h)-imidazolidinyl)urea; SBI-0051759.P002; KB-212681; ST2408512; TR-038622; A0211; AB00052307; BG01500390; FT-0604592; ST50308144; C01551; J10470; M-5668; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); AB00052307_11; I05-0376; J-522839; SR-01000766252-2; SR-01000766252-3; SR-01000766252-4; W-100104; I14-13401; Allantoin, European Pharmacopoeia (EP) Reference Standard; A999F0D6-0285-41D9-A6BA-B705987B663C; Allantoin, United States Pharmacopeia (USP) Reference Standard; Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material; Ao>>u(1/4)a paragraph signthorn-micro feminineA Ie-2,4- paragraph signthornI feminine; 37305-69-4; 5-Ureidohydantoin; Glyoxyldiureide; Glyoxylic diureide; Cordianine; Glyoxyldiureid; (2,5-Dioxo-4-imidazolidinyl)urea; 58308-55-7; Allantoin; Herpecin L; Herpecin-L; HerpecinL; Sebical; Woun’dres; 5-Ureidohydantoin, Glyoxylic(acid) diureide; (2,5-DIOXO-4-IMIDAZOLIDINYL) – UREA; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; GLYOXYLDIUREID; GLYOXYLDIUREIDE; GLYOXYLIC DIUREIDE; UREA, (2,5-DIOXO-4-IMIDAZOLIDINYL) -; UREA, (2,5DIOXO4IMIDAZOLIDINYL) ; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; AI3-15281; (±)-Allantoin; (±)-Allantoin; 1-(2,5-Dioxo-4-imidazolidinyl)harnstoff [German] [ACD/IUPAC Name]; 1-(2,5-Dioxo-4-imidazolidinyl)urea [ACD/IUPAC Name]; 1-(2,5-Dioxo-4-imidazolidinyl)urée [French] [ACD/IUPAC Name]; 1-(2,5-Dioxoimidazolidin-4-yl)harnstoff; 1-(2,5-dioxoimidazolidin-4-yl)urea; 2,5-Dioxo-4-imidazolidinyl-urea; 202-592-8 [EINECS]; 344S277G0Z; 39669-95-9 [RN]; 4H-imidazole-2,5-diol, 4-[(hydroxyiminomethyl)amino]-; 4-ureido-2,5-Imidazolidinedione; 5-Ureido-2,4-imidazolidindion; 5-ureido-Hydantoin; 97-59-6 [RN]; Allantoin [BAN] [JAN] [USAN] [USP] [Wiki]; Allantoin (8CI); DL-Allantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; UNII:344S277G0Z; Urea, (2,5-dioxo-4-imidazolidinyl)-; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); Urea, N-(2,5-dioxo-4-imidazolidinyl)- [ACD/Index Name]; 5-Ureidohydrantoin; Fancol TOIN; (2,5-diketoimidazolidin-4-yl)urea; (2,5-dioxo-4-imidazolidinyl)-urea; (2,5-Dioxo-4-imidazolidinyl)urea; (2,5-dioxoimidazolidin-4-yl)urea; (2,5-Dioxo-imidazolidin-4-yl)-urea; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; [97-59-6]; 2,5-dioxoimidazolidin-4-ylurea; 2,5-Imidazolidinedione, 4-ureido-; 5-Ureido-2,4-imidazolidindione; 5-Ureido-2,4-imidazolidinedione; Actinac; Alantan; Allantoi; allantoin 98%; Allantoin CTFA; allantoin standard; allantoin, ???; allantoin, 98%; allantoin, powder; Allantoinum; Allantol; Alloxantin [Wiki]; Alphosyl; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; AVC/Dienestrolcream; c4h6n4o3; Cordianin; Cutemol emollient; Dermalex; DL-ALLANTOIN-5-13C,1-15N; Glyoxyldiureid; Glyoxylic diureide; Glyoxylic(acid) diureide; Hemocane; Hydantoin, 5-ureido-; MFCD00005260 [MDL number]; N-(2,5-dioxoimidazolidin-4-yl)urea; Paxyl [Wiki]; Pharmakon1600-01500801; ProClin 300; Psoralon; S-allantoin; Sebical; Septalan; Uniderm A; Urea, (2, 5-dioxo-4-imidazolidinyl)-; Ureidohydantoin.; YT1600000; ??? [Chinese]; (2,5-Dioxo-4-imidazolidinyl)urea; 2,5-Dioxo-4-imidazolidinyl-urea; 4-ureido-2,5-imidazolidinedione; 5-Ureido-2,4-imidazolidindione; 5-Ureidohydantoin; 5-ureidohydantoin; glyoxyldiureide; N-(2,5-Dioxo-4-imidazolidinyl)urea; InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11); POJWUDADGALRAB-UHFFFAOYSA-N; Urea, (2,5-dioxo-4-imidazolidinyl)-; 1-(2,5-dioxoimidazolidin-4-yl)urea; Urea, (2,5-dioxo-4-imidazolidinyl)-; Allantol; AVC/Dienestrolcream; Cordianine; Glyoxyldiureid; Glyoxyldiureide; Hydantoin, 5-ureido-; Sebical; 5-Ureidohydantoin; 2,5-Dioxo-4-imidazolidinyl-urea; Alantan; Glyoxylic diureide; 5-Ureidohydrantoin; Fancol TOIN; Psoralon; Septalan; 2,5-Imidazolidinedione, 4-ureido-; NSC 7606; Urea, N-(2,5-dioxo-4-imidazolidinyl)-; allantoine>; allanton; allantone; allan ton; allan toine; allan ton; allan toin; ALLANTON; ALLANTOIN; ALLAN TOIN; ALLAN TONE; ALLAN TOINE; ALLAN TOIN; ALLANTOIN ; ALLANTON; allantoin; 97-59-6; 5-Ureidohydantoin; Glyoxyldiureide; 1-(2,5-dioxoimidazolidin-4-yl)urea; Glyoxyldiureid; Allantol; Cordianine; Sebical Alantan; AVC/Dienestrolcream; Urea, (2,5-dioxo-4-imidazolidinyl)-; Hydantoin, 5-ureido-; Cutemol emollient; Uniderm A; Glyoxylic diureide; (2,5-Dioxo-4-imidazolidinyl)urea; Psoralon; Septalan; Caswell No. 024; (2,5-dioxoimidazolidin-4-yl)urea; Glyoxylic(acid) diureide; 5-Ureido-2,4-imidazolidindion; NSC 7606; Ureidohydantoin; Allantoi; CCRIS 1958; Allantoin [USAN:BAN]; Fancol TOIN; 5-Ureidohydrantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; EPA Pesticide Chemical Code 085701; AI3-15281; NSC7606; 2,5-Dioxo-4-imidazolidinyl-urea; Allantoin (JAN/USP); EINECS 202-592-8; BRN 0102364; urea, N-(2,5-dioxo-4-imidazolidinyl)-; MLS000737882; C4H6N4O3; CHEBI:15676; 4-ureido-2,5-Imidazolidinedione; POJWUDADGALRAB-UHFFFAOYSA-N; MFCD00005260; N-(2,5-dioxoimidazolidin-4-yl)urea; DSSTox_CID_43; Herpecin L; D00121; DSSTox_RID_75334; DSSTox_GSID_20043; (S)-Allantoin; N-[2,5-dioxoimidazolidin-4-yl]urea; 5377-33-3; SMR000528073; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; allantion; Allantoinum; Hemocane; DL-Allantoin; Allantoin CTFA; HSDB 7490; Allantoin [USAN:USP:BAN:JAN]; CAS-97-59-6; Prestwick_11; NCGC00016358-01; 5-ureido-Hydantoin; Allantoin (8CI); 5-eaAoAOEO; (+/-)-Allantoin; Spectrum_001078; ACMC-209twn; Prestwick0_000002; Prestwick1_000002; Prestwick2_000002; Prestwick3_000002; Spectrum2_000219; Spectrum3_000876; Spectrum4_000716; Spectrum5_001526; bmse000437; D01HNL; AC1L18PM; AC1Q2AJ8; SCHEMBL3208; Oprea1_621175; Allantoin, 98% 250g; BSPBio_000003; BSPBio_002551; KBioGR_001271; KBioSS_001558; 5-25-15-00338 (Beilstein Handbook Reference); RSC679I2B; MLS002473300; Allantoin, analytical standard; Bio-0219; DivK1c_000281; SPECTRUM1500801; SPBio_000237; SPBio_001924; BPBio1_000005; CHEMBL593429; 5-Ureido-2,4-imidazolidindione; DTXSID3020043; CTK5H9420; HMS500O03; KBio1_000281; KBio2_001558; KBio2_004126; KBio2_006694; KBio3_002051; Allantoin, >=98.0% (N); MolPort-001-779-876; NINDS_000281; Urea,5-dioxo-4-imidazolidinyl)-; HMS1568A05; HMS1921I10; HMS2092K16; HMS2095A05; HMS2268N08; Pharmakon1600-01500801; component of Skin-balm (Salt/Mix); HY-N0543; NSC-7606; 2,5-Imidazolidinedione, 4-ureido-; Tox21_110395; Tox21_202087; Tox21_302912; ANW-43029; BBL027508; CCG-39781; NSC757792; SBB003997; STL373778; AKOS000120642; AKOS016038547; Tox21_110395_1; CS-7741; LS-7181; MCULE-1008326286; NSC-757792; RL06095; RTR-038622; SDCCGMLS-0066595.P001; 1-(2,5-Dioxoimidazolidin-4-yl);urea; IDI1_000281; KS-0000005S; Allantoin, p.a., 98.5-101.0%; N-(2,5-Dioxo-4-imidazolidinyl)urea #; NCGC00094854-01; NCGC00094854-02; NCGC00094854-03; NCGC00094854-04; NCGC00094854-05; NCGC00094854-07; NCGC00256403-01; NCGC00259636-01; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; 4CN-0784; AC-11040; AK-77679; AN-24454; AS-13865; BT000187; H736; HE033953; HE331747; HE420345; HE420346; NCI60_041675; SC-18051; N-(2,5-Dioxo-4(1h)-imidazolidinyl)urea; SBI-0051759.P002; KB-212681; ST2408512; TR-038622; A0211; AB00052307; FT-0604592; ST50308144; C01551; J10470; M-5668; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); AB00052307_11; SR-01000766252; I05-0376; J-522839; SR-01000766252-2; W-100104; I14-13401; Allantoin, European Pharmacopoeia (EP) Reference Standard; A999F0D6-0285-41D9-A6BA-B705987B663C; Allantoin, United States Pharmacopeia (USP) Reference Standard; Allantoin, pharmaceutical secondary standard; traceable to USP and PhEur; Ao>>u(1/4)a paragraph signthorn-micro feminineA Ie-2,4- paragraph signthornI feminine; 37305-69-5-; Ureidohydantoin; Glyoxyldiureide; Glyoxylic diureide; Cordianine; Glyoxyldiureid; (2,5-Dioxo-4-imidazolidinyl)urea; 58308-55-7; Glyoxyldiureide; 5-Ureidohydantoin; (2,5-DIOXO-4-IMIDAZOLIDINYL) – UREA; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; GLYOXYLDIUREID; GLYOXYLDIUREIDE; GLYOXYLIC DIUREIDE; UREA, (2,5-DIOXO-4-IMIDAZOLIDINYL) -; UREA, (2,5DIOXO4IMIDAZOLIDINYL); (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; 102364; C4H6N4O3; POJWUDADGALRAB-UHFFFAOYSA-N; ?98%; 5-Ureidohydantoin; Glyoxylic(acid) diureide; MFCD00005260; 202-592-8; Allantoin, ?98.0% (N); Allantoin, analytical standard; Allantoin, European Pharmacopoeia (EP) Reference Standard; Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material; Allantoin, United States Pharmacopeia (USP) Reference Standard; 5-Ureidohydantoin; Glyoxylic(acid) diureide; analytical standard; InChI KeyPOJWUDADGALRAB-UHFFFAOYSA-N; assay?98.0% (HPLC); 5397; ChEBI:15678; ChEMBL:CHEMBL1230080; PDB-CCD:3AL[PDBj]; 3DMET:B00428; NIKKAJI:J732.396D; FormulaC4H6N4O3; Exact mass 158.044; Mol weight158.1154; ALLANTON; ALLANTONE; ALLANTOINE; ALLANTOIN; allantone; allantoine; allantoin; allanton; allanton; allantan; allantaina; allantana; ALLONTON; allonton; allontoin; ALLONTOYIN; ALLONTOYN; allontoyn; allontoyin; (2,5-Dioxo-4-imidazolidinyl) urea; GLYOXYLDIUREIDE; glyoxyldurede; Glyoxyldiureide; gloksldure; gloksildiüre; GLOKSILDIURE; GLOKSLDÜRE; 5 UREIDOHYDANTOIN; 5 UREDOHYDANTON; 5 uredohydanton; 5 üreidohydantoin; 5-Ureidohydantoin; ALANTONE; ALANTON; ALLANTON; ALANTON; ALLANTaOIN; ALANTOIN; ALLANTONE; ALLANTONE; allantoine; allantoin; alantoin; alanton; allantoine; allantone; alantoine; allantoine; alanton; alanton; allanton; allantoin; allantoyin; alantoyin; allantoyne; allantoyn; allantoyin; allantoine; allantoyn; alantoyn; allatoyin; allantoyn; allantone; alantoyin; alantoyine; alantoyine;
Allantoin;
The skin is a natural actor proven to be refreshing and protective.
The US Food and Drug Administration (FDA) classified Allantoin as Category 1 (safe and effective) as a skin protector.
Although the working mechanism of Allantoin as a cosmetic raw material is still unclear, value and efficacy have been supported by many in-vitro and in-vivo tests
Even when allantoin is used at 0.3%, it is a highly effective anti-inflammatory. Because it is both effective and economical, it is widely used in over-the-counter topical formulations and cosmetic products.
Allantoin is used to promote natural renewal of the skin, to prevent irritation, to improve moisture retention capacity and to soften the skin.
Description
Allantoin is a substance that is endogenous to the human body and also found as a normal component of human diets [FDA Label]. In healthy human volunteers, the mean plasma concentration of allantoin is about 2-3 mg/l. During exercise, the plasma allantoin concentration rapidly increases about two fold and remains elevated [FDA Label]. In human muscle, urate is oxidized to allantoin during such exercise [FDA Label]. The concentration of allantoin in muscles increases from a resting value of about 5000 ug/kg to about 16000 ug/kg immediately after short-term exhaustive cycling exercise [FDA Label].
More specifically, allantoin is a diureide of glyoxylic acid that is produced from uric acid. It is a major metabolic intermediate in most organisms. Allantoin is found in OTC cosmetic products and other commercial products such as oral hygiene products, in shampoos, lipsticks, anti-acne products, sun care products, and clarifying lotions . Allantoin has also demonstrated to ameliorate the wound healing process in some studies
What it is ?
Allantoin is a white powder. It can be found in plants, like comfrey and horse chestnut, and in the urine of most mammals. The type that is most commonly used in cosmetics and skincare products though derives from urea and glyoxylic acid.
What it does ?
Allantoin has anti-irritant, soothing and healing properties: it calms down irritations, helps shed the upper layers of dead skin cells and promotes the growth of healthy tissue. That’s why it’s effective at treating wounds,eczema, psoriasis, burns and other skin conditions
Uses
Allantoin is useful for the treatment of wound, carbuncles, burns and sunburns, scalds, acne and skin eruptions, impetigo, psoriasis, eczema, fissures and abrasions.
Allantoin is an anti-aging ingredient used in facial rejuvenation products. It is a common ingredient of skin care products. It is proven effective in soothing irritated skin, stimulates cell regeneration and moisturizes dry skin.
In harnessing the effectiveness and benefits of allantoin, it is used in various facial cleaners, acne products, toners, sunscreens, moisturizers, and other specialty skin care products.
The derivatives of allantoin brought about personal care products such as follows:
• Deodorants and antiperspirants
• Shaving products
• Skin-astringent lotions
• Anti-Acne
• Foot preparations products
• Veterinary preparations products
• Dusting powder and cream
• Hair care products
• Anti-inflammatory products
Allantoin;
Cildi yenileyici ve koruyucu etkisi kantlanm doal bir aktiftir.
ABD Gda ve laç Dairesi (FDA) Allantoin’i Kategori 1 (güvenli ve etkili) de cilt koruyucu olarak snflandrmtr.
Bir kozmetik hammadde olarak Allantoin’in çalma mekanizmas hala net olarak anlalamam olmasna ramen, deeri ve etkinlii yaplan birçok in-vitro ve in-vivo testlerle desteklenmitir
Allantoin %0,3 kullanldnda bile oldukça etkili bir anti inflamatuardr. Hem etkisi hem de ekonomik olmas nedeniyle, reçetesiz topikal formülasyonlarda ve kozmetik ürünlerde yaygn olarak kullanlr.
Allantoin, cildin doal yenilenmesi desteklemek, tahri olmasn önlemek, nem tutma kapasitesini gelitirmek ve cildi yumuatmak için kullanlr.
Açklama
Allantoin insan vücuduna endojen olan ve ayn zamanda insan diyetlerinin normal bir bileeni olan [FDA Label] bir maddedir. Salkl insan gönüllülerinde, ortalama plazma plazma konsantrasyonu yaklak 2-3 mg / l’dir. Egzersiz srasnda, plazma allantoin konsantrasyonu hzla iki kat artar ve yüksek kalr [FDA Label]. nsan kasnda, bu egzersiz srasnda urat allantoine oksitlenir [FDA Label]. Kaslardaki allantoin konsantrasyonu, ksa süreli ar bisiklet egzersizinden [FDA Label] hemen sonra yaklak 5000 ug / kg ila yaklak 16000 µg / kg dinlenme deerinden artar.
Daha spesifik olarak, allantoin, ürik asitten üretilen bir glioksilik asit diüritidir. Çou organizmada önemli bir metabolik ara madde. Allantoin, OTC kozmetik ürünlerinde ve az hijyeni ürünleri, ampuanlar, rujlar, anti-akne ürünleri, güne bakm ürünleri ve arndrc losyonlar gibi dier ticari ürünlerde bulunur. Allantoin ayrca baz çalmalarda yara iyileme sürecini iyiletirdiini göstermitir.
Nedir ?
Allantoin beyaz bir tozdur. Karakafes ve at kestanesi gibi bitkilerde ve çou memelinin idrarnda bulunabilir. Kozmetik ve cilt bakm ürünlerinde en çok kullanlan tip, üre ve glioksilik asittir.
Ne yapar ?
Allantoin anti-tahri edici, yattrc ve iyiletirici özelliklere sahiptir: tahrileri yattrr, ölü deri hücrelerinin üst katmanlarn dökmeye yardmc olur ve salkl dokunun büyümesini destekler. Bu yüzden yaralarn, egzamalarn, sedeflerin, yanklarn ve dier cilt hastalklarnn tedavisinde etkilidir.
Kullanmlar
Allantoin, yara, carbuncles, yanklar ve sunburns, scalds, akne ve cilt döküntüleri, impetigo, sedef, egzama, çatlak ve syrklarn tedavisi için yararldr.
Allantoin yüz gençletirme ürünlerinde kullanlan yalanma kart bir maddedir. Cilt bakm ürünlerinin ortak bir maddesidir. Tahri olmu cildin yattrlmasnda etkilidir, hücre rejenerasyonunu uyarr ve kuru cildi nemlendirir.
Allantoinin etkililiini ve yararlarn deerlendirirken, çeitli yüz temizleyicileri, akne ürünleri, tonerler, güne kremleri, nemlendiriciler ve dier özel cilt bakm ürünlerinde kullanlr.
Allantoin türevleri aadaki gibi kiisel bakm ürünleri getirdi:
• Deodorantlar ve antiperspirantlar
• Tra ürünleri
• Cilt-büzücü losyonlar
• Sivilce Kart
• Ayak preparatlar ürünleri
• Veteriner preparatlar ürünleri
• Toz alma tozu ve kremi
• Saç bakm ürünleri
• Anti-inflamatuar ürünler